UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 92 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $504,000 | -57.9% | 168,158 | -34.8% | 0.00% | -100.0% |
Q2 2021 | $1,197,000 | +638.9% | 257,966 | +857.7% | 0.00% | – |
Q1 2021 | $162,000 | +16.5% | 26,936 | +1.7% | 0.00% | – |
Q4 2020 | $139,000 | +117.2% | 26,490 | +43.8% | 0.00% | – |
Q3 2020 | $64,000 | -59.2% | 18,426 | +1.6% | 0.00% | – |
Q2 2020 | $157,000 | +185.5% | 18,143 | +89.6% | 0.00% | – |
Q1 2020 | $55,000 | -24.7% | 9,568 | -5.7% | 0.00% | – |
Q4 2019 | $73,000 | +69.8% | 10,144 | +39.2% | 0.00% | – |
Q3 2019 | $43,000 | -42.7% | 7,285 | -9.6% | 0.00% | – |
Q2 2019 | $75,000 | -67.9% | 8,063 | -72.3% | 0.00% | – |
Q1 2019 | $234,000 | -49.6% | 29,101 | +1.8% | 0.00% | – |
Q4 2018 | $464,000 | +32.6% | 28,578 | +32.8% | 0.00% | – |
Q3 2018 | $350,000 | +32.1% | 21,526 | +21.5% | 0.00% | – |
Q2 2018 | $265,000 | – | 17,720 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
PDT Partners, LLC | 74,178 | $344,000 | 0.02% |